Your email has been successfully added to our mailing list.

×
-0.00688888888888887 -0.0233355555555555 -0.00688888888888887 -0.000222222222222198 -0.0222222222222221 -0.0226666666666666 -0.0222222222222221 -0.0246666666666667
Stock impact report

EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate [Yahoo! Finance]

Oragenics Inc. (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
Company Research Source: Yahoo! Finance
What Happened: A recent study shows that the drug successfully targets areas inside the nose connected to the brain, making the drug more likely to reach and treat the brain after a concussion. In the study, ONP-002 was tested using a nasal spray device. The goal of intranasal casting studies is to identify where the drug lands inside a cast metal anatomical model of the interior nose. The model is standard for intranasal drug delivery and is accepted by the FDA as a surrogate for the actual nasal passage. The results showed that the drug spreads well in the nose areas, where it can be quickly absorbed into the brain. Also Read: EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injury Why It Matters: Oragenics is now preparing to move forward with human testing (Phase 2) in patients who come to the emergency room with a concussion, aiming to give the first dose of the drug within 8 Show less Read more
Impact Snapshot
Event Time:
OGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
OGEN alerts

from News Quantified
Opt-in for
OGEN alerts

from News Quantified